<DOC>
	<DOCNO>NCT01285752</DOCNO>
	<brief_summary>To investigate efficacy safety AK106-001616 patient rheumatoid arthritis .</brief_summary>
	<brief_title>A Study AK106-001616 Patients With Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Diagnosis RA ( class I III ) Stable dose methotrexate ( least 12 week ) Pregnant breastfeed Abnormal screen laboratory test value consider clinically significant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>